Is retatrutide natural?
No. A paper on the late-stage trial programme calls it a novel synthetic molecule.
GLP-1 / GIP / glucagon triple agonistUpdated
Short answer
No. A paper on the late-stage trial programme calls it a novel synthetic molecule.[1]
A perspective paper says it exemplifies rational multi-agonist peptide engineering.[2]
A review describes it as a first-in-class unimolecular triple hormone receptor agonist: one engineered molecule rather than a mix of hormones.[3]
More questions on Retatrutide
More on Retatrutide
Sources
- 1Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials.Diabetes, obesity & metabolism · 2026PMID 41090431Accessed 2 Oct 2026
- 2The Triple-Agonist Revolution: Retatrutide and the Paradigm Shift in Multi-Hormonal Pharmacotherapy for Obesity and Cardiometabolic Comorbidities.Clinical pharmacology in drug development · 2026PMID 41545327Accessed 2 Oct 2026
- 3Triple Hormone Receptor Agonism: The Role of Retatrutide in Addressing Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Comprehensive Review.Cardiology in review · 2026PMID 42108533Accessed 2 Oct 2026
Found an error? Report a correction.